JP2024522201A5 - - Google Patents
Info
- Publication number
- JP2024522201A5 JP2024522201A5 JP2023576071A JP2023576071A JP2024522201A5 JP 2024522201 A5 JP2024522201 A5 JP 2024522201A5 JP 2023576071 A JP2023576071 A JP 2023576071A JP 2023576071 A JP2023576071 A JP 2023576071A JP 2024522201 A5 JP2024522201 A5 JP 2024522201A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- haloalkyl
- membered
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2108249.0A GB202108249D0 (en) | 2021-06-09 | 2021-06-09 | Compounds |
| GB2108249.0 | 2021-06-09 | ||
| PCT/KR2022/008105 WO2022260441A1 (en) | 2021-06-09 | 2022-06-09 | Preparation of substituted 1,2-diaminoheterocyclic compound derivatives and their use as pharmaceutical agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522201A JP2024522201A (ja) | 2024-06-11 |
| JP2024522201A5 true JP2024522201A5 (https=) | 2026-04-28 |
Family
ID=76838874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023576071A Pending JP2024522201A (ja) | 2021-06-09 | 2022-06-09 | 置換された１，２－ジアミノヘテロサイクリック化合物誘導体の製造およびその薬剤としての用途 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240300936A1 (https=) |
| EP (1) | EP4352049A4 (https=) |
| JP (1) | JP2024522201A (https=) |
| KR (1) | KR20240006692A (https=) |
| CN (1) | CN117529476A (https=) |
| AU (1) | AU2022291332A1 (https=) |
| CA (1) | CA3216629A1 (https=) |
| GB (1) | GB202108249D0 (https=) |
| MX (1) | MX2023014784A (https=) |
| WO (1) | WO2022260441A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250096877A (ko) * | 2022-12-12 | 2025-06-27 | 아벨로스테라퓨틱스 주식회사 | 치환된 헤테로고리 화합물 유도체 및 그의 약학적 용도 |
| WO2024137979A2 (en) * | 2022-12-23 | 2024-06-27 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Foxm1 inhibitors and their use in treating cancers |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2465405A (en) * | 2008-11-10 | 2010-05-19 | Univ Basel | Triazine, pyrimidine and pyridine analogues and their use in therapy |
| JP5743897B2 (ja) * | 2008-11-20 | 2015-07-01 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ | 化合物 |
| JP5856151B2 (ja) * | 2010-05-12 | 2016-02-09 | バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | Ａｔｒキナーゼ阻害剤として有用な２−アミノピリジン誘導体 |
| US9481670B2 (en) * | 2011-01-25 | 2016-11-01 | Sphaera Pharma Pte. Ltd. | Triazine compounds |
| US9604937B2 (en) * | 2012-11-27 | 2017-03-28 | Thomas Helledays Stiftelse For Medicinsk Forskning | Pyrimidine-2,4-diamine derivatives for treatment of cancer |
| CN106794181A (zh) * | 2014-06-04 | 2017-05-31 | 托马斯·黑勒戴药物研究基金会 | 用于治疗炎性和自身免疫性病况的mth1抑制剂 |
-
2021
- 2021-06-09 GB GBGB2108249.0A patent/GB202108249D0/en not_active Ceased
-
2022
- 2022-06-09 CN CN202280041809.1A patent/CN117529476A/zh active Pending
- 2022-06-09 JP JP2023576071A patent/JP2024522201A/ja active Pending
- 2022-06-09 WO PCT/KR2022/008105 patent/WO2022260441A1/en not_active Ceased
- 2022-06-09 MX MX2023014784A patent/MX2023014784A/es unknown
- 2022-06-09 EP EP22820568.8A patent/EP4352049A4/en active Pending
- 2022-06-09 KR KR1020237043163A patent/KR20240006692A/ko active Pending
- 2022-06-09 US US18/568,365 patent/US20240300936A1/en active Pending
- 2022-06-09 CA CA3216629A patent/CA3216629A1/en active Pending
- 2022-06-09 AU AU2022291332A patent/AU2022291332A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7326622B2 (ja) | Ｅｒｋ阻害剤としてのスピロ系化合物およびその使用 | |
| JP5596680B2 (ja) | 経口抗がん製剤 | |
| JP2024522201A5 (https=) | ||
| EP3490565A1 (en) | Chemokine receptor modulators and uses thereof | |
| JP2010509375A5 (https=) | ||
| JPWO2019195124A5 (https=) | ||
| EP2305642A3 (en) | Bis(thio-hydrazide amide) salts for treatment of cancers | |
| JP2021534108A5 (https=) | ||
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| CN102584830A (zh) | 二氢化茚酰胺化合物、其药物组合物及其用途 | |
| JP2017524003A (ja) | 薬物耐性癌の治療で用いるための脂肪酸シンターゼ阻害剤 | |
| TWI719138B (zh) | 四氫異喹啉衍生物 | |
| CN115916966A (zh) | Strad结合剂及其用途 | |
| US10947225B2 (en) | Phosphotidylinositol 3-kinase inhibitors | |
| EP3307323A1 (en) | Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof | |
| WO2024061097A1 (zh) | 一种新颖的氨基甲酸酯类化合物及其用途 | |
| JP2002503674A5 (https=) | ||
| CN116621856A (zh) | 一种新颖的氨基甲酸酯类化合物及其用途 | |
| JP7245397B2 (ja) | 複素環化合物 | |
| KR920016418A (ko) | Nmda 길항제 | |
| JP7663605B2 (ja) | ピリミジン系三環式化合物及びその使用 | |
| JP2997894B2 (ja) | 循環器系疾患の予防及び治療剤 | |
| KR20230049673A (ko) | 피리미딘 카르복스아미드 화합물 및 이의 용도 | |
| JP6545254B2 (ja) | リン含有フェナントロリン誘導体及びその調製方法と応用 | |
| JP2006506319A5 (https=) |